The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
APPLIED GENETIC TECHNOLOGIES INC. COM 03820J100 5,019 246,005 SH   SOLE 1,2 0 0 246,005
CARA THERAPEUTICS, INC. COM 140755109 10,489 622,140 SH   SOLE 1,2 0 0 622,140
ONCOSEC MEDICAL INC. COM 68234L207 3,063 1,292,614 SH   SOLE 1,2 0 0 1,292,614
TRILLIUM THERAPEUTICS INC. COM 89620X506 4,672 370,537 SH   SOLE 1,2 0 0 370,537